Dame Carol Robinson
Member of the Scientific Advisory Board

    Carol Robinson holds the University Chair of Dr. Lee’s Professor of Chemistry and is the first Director of the Kavli Institute for Nanoscience Discovery at Oxford. She is recognised for establishing mass spectrometry as a viable technology to study the structure, function and interactions of proteins and their complexes. Her collaborations span both academic and industrial laboratories and in 2016, her spin-out company, OMass Technologies, was founded. Now trading as OMass Therapeutics the company uses high definition native mass spectrometry to develop drug therapies for use in immunologic and genetic disorders. Carol graduated from the Royal Society of Chemistry in 1979 and completed her PhD at the University of Cambridge. She took a career break of eight years to bring up her children and later became the first female Professor of Chemistry at the University of Cambridge (2001-2009). She has held the Dr. Lee’s Chair in Chemistry since 2009 and is Oxford’s first female Professor of Chemistry. Her research has attracted numerous international awards and distinctions. Her most recent awards are: The 2022 Benjamin Franklin Medal in Chemistry, The 2022 Louis Jeantet Prize for Medicine, The European Chemistry Gold Medal from the European Chemistry Society (EuChemS), The Othmer Gold Medal from the Science History Institute, The Academy Prize from the Royal Academy of Belgium and The Royal Medal A from the Royal Society. Her distinctions include International Honorary Member of the American Academy of Arts and Sciences (2021), Foreign Associate of the US National Academy of Sciences (2017), Dame Commander of the Order of the British Empire (DBE) in 2013 for her contributions to Science and Industry; she is also a former President of the UK Royal Society of Chemistry.

    Join Replay

    Help us to author the future of genomic medicine